Stent thrombosis: Historical perspectives and current trends

Journal of Thrombosis and Thrombolysis

Volumn 10, Issue 1, 2000, Pages 89-101

  Cutlip, D E ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Coronary artery; Myocardial infarction; Review

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DEXTRAN; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE; WARFARIN;

ACUTE HEART INFARCTION; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DISEASE ASSOCIATION; DOG; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL MODEL; HUMAN; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; RESTENOSIS; REVIEW; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0033806824     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018763108106     Document Type: Review

References (91)

1. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators
2. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group
3. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators
4. Stenting in chronic coronary occlusion (SICCO): A randomized trial of adding stent implantation after successful angioplasty
5. Acute 30 day and late clinical events in the randomized parallel-group comparison of the ACS Multi-link coronary stent system and the Palmaz-Schatz stent
6. Results of the NIRVANA equivalency trial comparing the NIR Primo stent to the Palmz-Schatz stent
7. Six-month clinical and angiographic results of the SMART trial
8. Final acute 30-day and 6-month clinical and angiographic outcome from the multicenter randomized EXTRA trial comparing the operator mounted XT and Palmaz-Schatz coronary stent
9. Angiographic follow-up after placement of a self-expanding coronary-artery stent
10. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty
11. Emergency stenting for refractory acute coronary artery occlusion during coronary angioplasty
12. Who was thrombogenic: The stent or the doctor?
13. A view of vascular stents
14. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study
15. Angiographic and clinical outcome of intracoronary stenting: Immediate and long-term results from a large single-center experience
16. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty
17. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty
18. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents
19. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design
20. Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcome
21. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes
22. Serial angiographic follow-up after Palmaz-Schatz stent implantation: Comparison with conventional balloon angioplasty
23. Thrombosis and restenosis after stenting in failed angioplasty: Comparison with elective stenting
24. Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group
25. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group
26. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators
27. The benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents
28. Intracoronary ultrasound observations during stent implantation
29. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance
30. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation
31. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation
32. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results form the multicenter ultrasound stenting in coronaries study (MUSIC Study)
33. Intracoronary stenting without coumadin: 1 month results of a French multicenter study
34. Intravascular ultrasound analysis of routine high pressure post-dilation after Palmaz-Schatz stent deployment
35. Subacute stent thrombosis: Evolving issues and current concepts
36. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation
37. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
38. A clinical trial comparing three anti-thrombotic drug regimens after coronary artery stenting
39. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting - The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study
40. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II pilot study
41. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
42. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multi-center aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
43. American College of Cardiology experts consensus document: Coronary artery stents
44. Stent thrombosis revisited
45. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement. Analysis of a prospective risk stratification protocol in the intracoronary stenting and antithrombotic regimen (ISAR) trial
46. Acute and 9-month clinical outcomes after 'sub-optimal' coronary stenting: Results from the stent anti-thrombotic regimen study (STARS) registry
47. The antiplatelet effects of ticlopidine and clopidogrel
48. Ticlopidine: An updated review of its pharmacology and therapeutic use in platelet dependent disorders
49. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures
50. The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q wave myocardial infarctions
51. Ticlopidine pretreatment prior to stenting is associated with a sustained reduction in cardiac events out to 1 y: Results from the EPISTENT trial
52. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation
53. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting
54. Clopidogrel versus ticlopidine after intracoronary stent placement
55. The Rx multi-link stent parallel registries to the ASCENT trial
56. Predictors and clinical outcomes of stent thrombosis - A pooled analysis of 5000 patients from multicenter randomized trials
57. Emergency stenting for acute occlusion after coronary balloon angioplasty
58. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: Frequency, predictors, and clinical outcome
59. Intra-coronary stent implantation without ultrasound guidance and with replacement of conventional anti-coagulation by antiplatelet therapy: 30 day clinical outcome of the French multicenter registry
60. Stent thrombosis: Incidence and related factors in the R.I.S.E. registry (Registro Impianto Stent Endocoronarico)
61. Coronary Palmaz-Schatz stent implantation in acute myocardial infarction
62. Coronary stent placement in patients with acute myocardial infarction: Comparison of clinical and angiographic outcomes after randomization to antiplatelet or anti-coagulant therapy
63. Stenting in acute myocardial infarction (STAMI): Bailout, conditional, and planned stents
64. Early versus late coronary stenting following acute myocardial infarction: Results of the STENTIM I Study (French registry of stenting in acute myocardial infarction
65. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI stent pilot trial
66. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence randomized elective stenting in acute coronary occlusions (FRESCO) trial
67. Primary coronary infarct artery stenting in acute myocardial infarction
68. Coronary angioplasty with or without stent implantation for acute myocardial infarction
69. Stratification of the risk of thrombosis after intracoronary stenting for threatened or acute closure complicating coronary coronary balloon angioplasty: A Cook registry study
70. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study Investigators
71. Intracoronary stenting in the treatment of acute or threatened closure in angiographically small coronary arteries (<3.0 mm) complicating percutaneous transluminal coronary angioplasty
72. Long stenting in native coronary arteries: Relation between vessel size and outcome
73. Bail-out stenting in small vessels: Preliminary in-hospital results of the ULTRA acute or threatened closure registry
74. A randomized comparison of elective stenting and balloon angioplasty in the treatment of small coronary arteries
75. Small native coronary vessel stenting: Results from the Asia Pacific Mini-Crown registry
76. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure
77. Risk factors for acute and subacute stent thrombosis after high-pressure stent implantation; a study by intravascular ultrasound
78. Stented segment length as an independent predictor of restenosis
79. Multiple stent implantation in single coronary arteries: Acute results and six-month angiographic follow-up
80. Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation
81. Treatment of acute stent thrombosis with local urokinase therapy using catheter-based, drug delivery systems: A case report
82. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis
83. Porcine model of stent thrombosis: Platelets are the primary component of acute stent closure
84. Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement
85. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases
86. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting
87. Rapid onset of inhibition of ADP-induced platelet aggregation by a loading dose of clopidogrel
88. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk for ischemic events (CAPRIE)
89. Aspirin and clopidogrel combination therapy in coronary stenting: A prospective registry
90. Randomized placebo-controlled and balloon angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
91. Abciixmab associated with primary angioplasty and stenting in acute myocardial infarction: The ADMIRAL Study, 30-day final results